Phytoestrogens and prostate cancer: Possible preventive role

Medical Journal of Australia

Volumn 167, Issue 3, 1997, Pages 138-140

  Stephens, Frederick O ^a,b  

^a ROYAL PRINCE ALFRED HOSPITAL   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ISOFLAVONE DERIVATIVE; PHYTOESTROGEN; UNCLASSIFIED DRUG;

AGED; APOPTOSIS; ARTICLE; CANCER HORMONE THERAPY; CANCER PREVENTION; CASE REPORT; ESTROGEN ACTIVITY; HISTOPATHOLOGY; HUMAN; MALE; ORAL DRUG ADMINISTRATION; PROSTATE ADENOCARCINOMA; PROSTATE CANCER; PROSTATECTOMY; TUMOR REGRESSION;

EID: 0030791916     PISSN: 0025729X     EISSN: None     Source Type: Journal    
DOI: 10.5694/j.1326-5377.1997.tb138812.x     Document Type: Article

References (29)

1. Muir CS, Nectoux J, Staszewski J. The epidemiology of prostate cancer. Geographical distribution and time trends. Acta Oncol 1991; 30: 133-140.
2. Armstrong BJ. Cancer in NSW. Incidence and mortality 1994. Sydney: NSW Cancer Council, August 1997.
3. Schroder FH. Current concepts in the management of prostatic cancer. Am J Clin Oncol 1988; 11 Suppl 1: S1-S5.
4. Carter BS, Cater HB, Isaacs JT. Epidemiologic evidence regarding predisposing factors to prostate cancer. Prostate 1996; 16: 187-197.
5. Donn AS, Muir CS. Prostatic cancer - some epidemiological features. Bull Cancer (Paris) 1985; 72: 381-390.
6. Adlercreutz H, Honjo H, Higashi A, et al. Urinary excretion of lignans and isoflavonoid phytoestrogens in Japanese men and women consuming a traditional Japanese diet. Am J Clin Nutr 1991; 54: 1093-1100.
7. Hellstrom M, Haggman M, Brandstedt S, et al. Histopathological changes in androgen-deprived localised prostatic cancer. A study of total prostatectomy specimens. Eur Urol 1993; 24: 461-465.
8. Ford LG, Brawlew OW, Pearlman JA, et al. The potential for hormonal prevention trials. Cancer 1994; 74 Suppl 9: 2726-2733.
9. Walker AR. Prostate cancer - some aspects of epidemiology, risk factors, treatment, and survival. S Afr Med J 1986; 69: 44-47.
10. Lee C, Lee ES, Choi H, et al. Incidence, estimation of genito-urinary cancer in Korea. J Korean Med Sci 1992; 7: 154-161.
11. Kolonel LN, Nomura AM, Hinds MW, et al. Role of diet in cancer incidence in Hawaii. Cancer Res 1983; 43: 2397-2402.
12. Lanier AP, Bulkow RL, Ireland B. Cancer in Alaskan Indians, Eskimos, and Aleuts, 1969-1983; implications for aetiology and control. Public Health Rep 1989; 104: 658-664.
13. Yu H, Harris RE, Gao YT, et al. Comparative epidemiology of cancers of the colon, rectum, prostate and breast in Shanghai, China, versus the United States. Int J Epidemiol 1991; 20: 76-81.
14. Hsing AW, McLaughlin JK, Zheng W, et al. Occupation, physical activity, and risk of prostate cancer in Shanghai, People's Republic of China. Cancer Causes Control 1994; 5: 136-140.
15. Friis S, Kjaer SK, Tjonneland AM, et al. Relationship between diet, nutritional status and prostatic cancer. Ugeskr Laeger 1994; 156: 3478-3484.
16. Kolonel LN, Yoshizawa CN, Hankin JH. Diet and prostatic cancer: A case control study in Hawaii. Am J Epidemiol 1988; 127: 999-1012.
17. Shimuzu H, Ross RK, Bernstein L, et al. Cancers of the prostate and breast among Japanese and white immigrants. Br J Cancer 1991; 63: 963-966.
18. Ogunlewe JO, Osegbe DN. Zinc and cadmium concentrations in indigenous blacks with normal, hypertrophic and malignant prostate. Cancer 1989; 63: 1388-1392.
19. Pienta KJ, Esper PS. Risk factors for prostate cancer. Ann Intern Med 1983; 118: 793-803.
20. Whittmore AS, Kolonel LN, Wu AH, et al. Prostate cancer in relation to diet, physical activity, and body size in relation to blacks, whites and Asians in the United States and Canada. J Natl Cancer Inst 1995; 87: 629-631.
21. Pusateri DJ, Roth WT, Ross JK, Schultz TD. Dietary and hormonal evaluation of men at different risks for prostate cancer; plasma and fecal hormone nutrient inter-relationships. Am J Clin Nutr 1990; 51: 371-377.
22. Meikle AW, Smith JA Jnr. Epidemiology of prostate cancer. Urol Clin North Am 1990; 17: 709-718.
23. Wynder EL, Laakso K, Sotarauta M, Rose DR Metabolic epidemiology of prostate cancer. Prostate 1984; 5: 47-53.
24. Griffiths K, Adlercreutz H, Boyle P, et al. Nutrition and cancer. Oxford: Isis Medical Media, 1996.
25. Adlercreutz H. Western diet and western diseases; some hormonal and biochemical mechanisms and associations. Scand J Clin Lab Invest Suppl 1990; 201: S3-S23.
26. Keung WM. Dietary estrogenic isoflavones are potent inhibitors of beta-hydroxy steroid dehydrogenase of P. testosteronii. Biochem Biophys Res Commun 1995; 215: 1137-1144.
27. Huggins C, Hodges C. Studies on prostatic cancer. 1. The effect of castration, of estrogens and androgen ingestion on serum phosphatases in metastatic carcinoma of the prostate. Cancer Res 1941; 1: 293-297.
28. Evans BA, Griffiths K, Morton MS. Inhibition of 5-alpha reductase in genital skin fibroblasts and prostate tissue by dietary lignans and isoflavonoids. J Endocrinol 1995; 147: 295-302.
29. Cassidy A, Bingham S, Satchell KDR. Biological effects of a diet of soy protein rich in isoflavones on the menstrual cycle of premenopausal women. Am J Clin Nutr 1994; 60: 333-340.